53 SUPPLY CHAINS TO ADMIRE | 2025
53
Table 37. Pharmaceuticals Sector Evaluation for the Period of 2015-2024
INDUSTRY: Pharmaceuticals
COMPANY INFORMATION
IMPROVEMENT
PERFORMANCE
VALUE
MARKET CAPITALIZIATION PER EMPLOYEE
PRICE TO BOOK
RETURN ON CAPITAL EMPLOYED
GROWTH (Year Over Year Revenue)
SUPPLY CHAIN FUNDAMENTAL SCORE
INVENTORY TURNS
OPERATING MARGIN
SUPPLY CHAIN INDEX
2024 REVENUE
NAME
2015 - 2024
Abbott Laboratories
$ 41,950
5
9
8.1%
3.24
14.7%
9.8%
4.54 1,434,466
AbbVie Inc
$ 56,334
4
7
11.5%
4.41
29.7%
13.9%
22.78 4,722,706
Amgen
$ 33,424
6
13
5.4%
1.45
36.7%
16.5%
15.15 5,729,062
Aspen Pharmacare Holdings Ltd
$ 2,386
4
24
-0.8%
1.36
23.1%
8.7%
1.67 713,511
Astellas Pharma Inc
$ 11,113
4
31
-0.2%
1.80
13.8%
13.3%
2.27 1,753,795
AstraZeneca plc
$ 54,073
3
12
8.2%
1.74
10.9%
8.6%
6.36 1,822,531
Baxter International Inc.
$ 10,636
3
14
0.2%
3.54
8.9%
7.6%
3.71 585,743
Bayer
$ 50,444
4
29
-0.3%
1.64
11.2%
3.3%
1.81 610,044
Biogen Idec Inc.
$ 9,676
5
18
0.4%
1.59
36.3%
22.0%
3.87 6,006,404
Biomarin Pharmaceutical Inc
$ 2,854
4
32
14.5%
0.57
-5.9%
-1.8%
4.58 5,681,957
Bristol-Myers Squibb Co.
$ 48,300
3
1
12.9%
4.39
16.9%
11.0%
5.25 4,053,433
Cencora Inc
$ 293,959
4
27
9.5%
0.00
1.1%
8.5%
43.10 853,589
Daiichi Sankyo Co Ltd
$ 11,099
4
15
2.3%
1.85
9.8%
6.6%
3.47 2,262,571
Eli Lilly and Company
$ 45,043
5
4
9.1%
1.42
27.1%
18.1%
26.92 6,503,239
Gilead Sciences
$ 28,754
3
5
2.2%
3.91
45.3%
21.1%
4.84 8,218,281
GlaxoSmithKline
$ 40,100
3
22
1.2%
1.74
19.8%
14.6%
52.87 885,307
Ipsen SA
$ 3,869
3
22
8.4%
2.35
23.3%
16.4%
3.61 1,527,621
Johnson & Johnson
$ 88,821
5
21
1.9%
2.67
26.1%
15.1%
5.46 2,789,110
Merck and Company
$ 64,168
5
7
4.6%
2.58
19.9%
13.2%
5.74 2,904,715
Novartis AG
$ 51,722
4
10
-0.1%
2.19
20.2%
12.6%
3.25 1,862,469
Novo Nordisk A/S
$ 42,134
5
16
10.7%
1.16
43.3%
79.5%
20.87 4,249,777
Perrigo Co PLC
$ 4,373
4
6
4.7%
2.82
9.1%
-1.2%
1.24 724,887
Pfizer, Inc.
$ 63,627
2
11
7.1%
1.93
23.3%
9.6%
3.02 2,500,490
Regeneron Pharmaceuticals Inc
$ 14,202
3
16
21.0%
0.77
37.6%
27.0%
5.77 6,882,784
Roche Holding
$ 70,890
4
26
3.3%
2.32
27.0%
26.5%
9.31 2,660,871
Sanofi S.A.
$ 47,933
5
24
5.9%
2.03
20.6%
15.5%
10.32 3,084,915
Santen Pharmaceutical Co Ltd
$ 2,093
5
18
3.9%
2.80
16.0%
11.8%
2.17 1,635,283
Teva Pharmaceutical Industries Limited
$ 16,544
2
30
-1.7%
2.18
19.3%
-3.3%
1.55 486,587
United Therapeutics Corp
$ 2,877
4
1
8.9%
1.41
43.5%
27.9%
2.55 8,667,480
Vertex Pharmaceuticals inc
$ 111,020
3
18
35.9%
2.44
23.7%
14.3%
12.18 16,095,552
West Pharmaceutical Services
$ 2,893
6
3
7.8%
4.81
18.9%
18.4%
7.87 1,677,879
Zoetis Inc
$ 9,256
4
27
6.9%
1.20
32.7%
22.4%
19.27 5,255,473
MEAN WITH OUTLIERS
$ 41,768
4
6.7%
2.20
22.0%
15.2%
9.92 3,588,829
MEAN WITHOUT OUTLIERS
5.7%
2.19
21.9%
15.3%
6.51 3,185,386
Made with FlippingBook - PDF hosting